{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:21:52Z","timestamp":1793924512788,"version":"4.8.0"},"reference-count":103,"publisher":"Bentham Science Publishers Ltd.","issue":"21","funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca-MIUR, PRIN 2017","doi-asserted-by":"publisher","award":["2017BMK8JR"],"award-info":[{"award-number":["2017BMK8JR"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Sulfur and oxygen containing-compounds are a relevant class of derivatives\nthat is constantly growing due to their wide range of pharmacological activity, including\nthe antiviral one. As proof of this, there are several FDA approved antiviral compounds\nhaving sulfur and oxygen in their structures. Among RNA viruses, the flavivirus genus\n(e.g. Dengue, West Nile, Yellow Fever and Zika viruses) holds a relevant place within\nzoonotic pathogens and thus flavivirus infections are considered a growing risk for the\npublic health. As a consequence, the drug discovery process aimed at identify new anti-\nflavivirus agents is of great relevance and will help to find effective therapies not available\nyet. One of the most alarming features of flaviviruses is their ability to co-infect the\nhost, thus aggravating the symptoms of the disease. Therefore, finding compounds endowed\nwith a broad-spectrum anti-flavivirus activity is now becoming a pressing need.\nIn this review, we describe the most promising compounds having both sulfur and oxygen\nin their structures characterized by a broad-spectrum activity against different flaviviruses.\nFurthermore, the synthetic procedures applied for the preparation of the described\nderivatives are also reported. Readers can be inspired by the contents of this review\nto design and synthesize more effective anti-flavivirus agents as well as to select viral\nor host targets to achieve an antiviral activity as broadly as possible.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867329666220610211441","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T06:22:35Z","timestamp":1655274155000},"page":"2396-2420","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Broad-Spectrum Anti-Flavivirus Activity and Chemistry of Compounds\nContaining Sulfur and Oxygen Chalcogens"],"prefix":"10.2174","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6604-4140","authenticated-orcid":true,"given":"Maria","family":"Sole Burali","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Universit\u00e0 degli Studi di Perugia, via del Liceo, 1-06123 Perugia,\nItaly"},{"name":"Medicinal Chemistry Laboratories, Rega Institute for Medical Research, KU Leuven, Herestraat 49\nbox 1041, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8558-7004","authenticated-orcid":true,"given":"Violetta","family":"Cecchetti","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Universit\u00e0 degli Studi di Perugia, via del Liceo, 1-06123 Perugia,\nItaly"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0207-3927","authenticated-orcid":true,"given":"Giuseppe","family":"Manfroni","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Universit\u00e0 degli Studi di Perugia, via del Liceo, 1-06123 Perugia,\nItaly"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"12009","DOI":"10.1038\/s41598-018-30614-3","volume":"8","author":"Wang S.","year":"2018","unstructured":"Wang S.; Tian H.; Ren C.; Yu J.; Sun M.; Electronic and optical properties of heterostructures based on transition metal dichalcogenides and graphene-like zinc oxide. Sci Rep 2018,8(1),12009","journal-title":"Sci Rep"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.ejmech.2019.07.043","volume":"180","author":"Pathania S.","year":"2019","unstructured":"Pathania S.; Narang R.K.; Rawal R.K.; Role of sulphur-heterocycles in medicinal chemistry: An update. Eur J Med Chem 2019,180,486-508","journal-title":"Eur J Med Chem"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/cmdc.201800119","volume":"13","author":"Singh P.K.","year":"2018","unstructured":"Singh P.K.; Silakari O.; The current status of O-heterocycles: A synthetic and medicinal overview. ChemMedChem 2018,13(11),1071-1087","journal-title":"ChemMedChem"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.2174\/1568026615666150915111741","volume":"16","author":"Feng M.","year":"2016","unstructured":"Feng M.; Tang B.; Liang S.H.; Jiang X.; Sulfur containing scaffolds in drugs: Synthesis and application in medicinal chemistry. Curr Top Med Chem 2016,16(11),1200-1216","journal-title":"Curr Top Med Chem"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s41061-018-0184-5","volume":"376","author":"Scott K.A.","year":"2018","unstructured":"Scott K.A.; Njardarson J.T.; Analysis of US FDA-approved drugs containing sulfur atoms. Top Curr Chem (Cham) 2018,376(1),5","journal-title":"Top Curr Chem (Cham)"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/molecules24213839","volume":"24","author":"Jampilek J.","year":"2019","unstructured":"Jampilek J.; Heterocycles in medicinal chemistry. Molecules 2019,24(21),10-13","journal-title":"Molecules"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1128\/AAC.47.10.3123-3129.2003","volume":"47","author":"Koh Y.","year":"2003","unstructured":"Koh Y.; Nakata H.; Maeda K.; Ogata H.; Bilcer G.; Devasamudram T.; Kincaid J.F.; Boross P.; Wang Y-F.; Tie Y.; Volarath P.; Gaddis L.; Harrison R.W.; Weber I.T.; Ghosh A.K.; Mitsuya H.; Novel bis-tetrahydrofuranylurethane-containing nonpeptidic protease inhibitor (PI) UIC-94017 (TMC114) with potent activity against multi-PI-resistant human immunodeficiency virus in vitro. Antimicrob Agents Chemother 2003,47(10),3123-3129","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1021\/acschembio.9b00675","volume":"15","author":"Timm J.","year":"2020","unstructured":"Timm J.; Kosovrasti K.; Henes M.; Leidner F.; Hou S.; Ali A.; Kurt Yilmaz N.; Schiffer C.A.; Molecular and structural mechanism of pan-genotypic HCV NS3\/4A protease inhibition by glecaprevir. ACS Chem Biol 2020,15(2),342-352","journal-title":"ACS Chem Biol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1016\/j.bmcl.2019.03.037","volume":"29","author":"Taylor J.G.","year":"2019","unstructured":"Taylor J.G.; Zipfel S.; Ramey K.; Vivian R.; Schrier A.; Karki K.K.; Katana A.; Kato D.; Kobayashi T.; Martinez R.; Sangi M.; Siegel D.; Tran C.V.; Yang Z-Y.; Zablocki J.; Yang C.Y.; Wang Y.; Wang K.; Chan K.; Barauskas O.; Cheng G.; Jin D.; Schultz B.E.; Appleby T.; Villase\u00f1or A.G.; Link J.O.; Discovery of the pan-genotypic hepatitis C virus NS3\/4A protease inhibitor voxilaprevir (GS-9857): A component of Vosevi. Bioorg Med Chem Lett 2019,29(16),2428-2436","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=10","first-page":"241","volume":"7","author":"Izquierdo L.","year":"2014","unstructured":"Izquierdo L.; Helle F.; Fran\u00e7ois C.; Castelain S.; Duverlie G.; Brochot E.; Simeprevir for the treatment of hepatitis C virus infection. Pharm Genom Pers Med 2014,7,241-249","journal-title":"Pharm Genom Pers Med"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules26144230","volume":"26","author":"Santi C.","year":"2021","unstructured":"Santi C.; Scimmi C.; Sancineto L.; Ebselen and analogues: Pharmacological properties and synthetic strategies for their preparation. Molecules 2021,26(14),1-25","journal-title":"Molecules"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","volume":"582","author":"Jin Z.","year":"2020","unstructured":"Jin Z.; Du X.; Xu Y.; Deng Y.; Liu M.; Zhao Y.; Zhang B.; Li X.; Zhang L.; Peng C.; Duan Y.; Yu J.; Wang L.; Yang K.; Liu F.; Jiang R.; Yang X.; You T.; Liu X.; Yang X.; Bai F.; Liu H.; Liu X.; Guddat L.W.; Xu W.; Xiao G.; Qin C.; Shi Z.; Jiang H.; Rao Z.; Yang H.; Structure of M from SARS-CoV-2 and discovery of its inhibitors. Nature 2020,582(7811),289-293","journal-title":"Nature"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1128\/AAC.02574-15","volume":"60","author":"Thenin-Houssier S.","year":"2016","unstructured":"Thenin-Houssier S.; de Vera I.M.S.; Pedro-Rosa L.; Brady A.; Richard A.; Konnick B.; Opp S.; Buffone C.; Fuhrmann J.; Kota S.; Billack B.; Pietka-Ottlik M.; Tellinghuisen T.; Choe H.; Spicer T.; Scampavia L.; Diaz-Griffero F.; Kojetin D.J.; Valente S.T.; Ebselen, a small-molecule capsid inhibitor of HIV-1 replication. Antimicrob Agents Chemother 2016,60(4),2195-2208","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1016\/S1473-3099(16)30518-7","volume":"17","author":"Wilder-Smith A.","year":"2017","unstructured":"Wilder-Smith A.; Gubler D.J.; Weaver S.C.; Monath T.P.; Heymann D.L.; Scott T.W.; Epidemic arboviral diseases: Priorities for research and public health. Lancet Infect Dis 2017,17(3),e101-e106","journal-title":"Lancet Infect Dis"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jcv.2016.10.024","volume":"85","author":"Azevedo R.S.S.","year":"2016","unstructured":"Azevedo R.S.S.; Araujo M.T.; Martins Filho A.J.; Oliveira C.S.; Nunes B.T.D.; Cruz A.C.R.; Nascimento A.G.P.A.C.; Medeiros R.C.; Caldas C.A.M.; Araujo F.C.; Quaresma J.A.S.; Vasconcelos B.C.B.; Queiroz M.G.L.; da Rosa E.S.T.; Henriques D.F.; Silva E.V.P.; Chiang J.O.; Martins L.C.; Medeiros D.B.A.; Lima J.A.; Nunes M.R.T.; Cardoso J.F.; Silva S.P.; Shi P.Y.; Tesh R.B.; Rodrigues S.G.; Vasconcelos P.F.C.; Zika virus epidemic in Brazil. I. Fatal disease in adults: Clinical and laboratorial aspects. J Clin Virol 2016,85,56-64","journal-title":"J Clin Virol"},{"key":"ref=16","first-page":"1","volume":"7","author":"Saiz J.C.","year":"2016","unstructured":"Saiz J.C.; V\u00e1zquez-Calvo \u00c1.; Bl\u00e1zquez A.B.; Merino-Ramos T.; Escribano-Romero E.; Mart\u00edn-Acebes M.A.; Zika virus: The latest newcomer. Front Microbiol 2016,7,1-19","journal-title":"Front Microbiol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jcv.2014.08.030","volume":"64","author":"Monath T.P.","year":"2015","unstructured":"Monath T.P.; Vasconcelos P.F.C.; Yellow fever. J Clin Virol 2015,64,160-173","journal-title":"J Clin Virol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s13365-014-0285-z","volume":"20","author":"Daep C.A.","year":"2014","unstructured":"Daep C.A.; Mu\u00f1oz-Jord\u00e1n J.L.; Eugenin E.A.; Flaviviruses, an expanding threat in public health: Focus on dengue, West Nile, and Japanese encephalitis virus. J Neurovirol 2014,20(6),539-560","journal-title":"J Neurovirol"},{"key":"ref=19","year":"2019","unstructured":"Ten threats to global health. WHO Available from: 2019"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s12026-008-8065-6","volume":"43","author":"Robertson S.J.","year":"2009","unstructured":"Robertson S.J.; Mitzel D.N.; Taylor R.T.; Best S.M.; Bloom M.E.; Tick-borne flaviviruses: Dissecting host immune responses and virus countermeasures. Immunol Res 2009,43(1-3),172-186","journal-title":"Immunol Res"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/nrd.2017.33","volume":"16","author":"Boldescu V.","year":"2017","unstructured":"Boldescu V.; Behnam M.A.M.; Vasilakis N.; Klein C.D.; Broad-spectrum agents for flaviviral infections: Dengue, Zika and beyond. Nat Rev Drug Discov 2017,16(8),565-586","journal-title":"Nat Rev Drug Discov"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1021\/acs.jmedchem.9b00775","volume":"63","author":"Bernatchez J.A.","year":"2020","unstructured":"Bernatchez J.A.; Tran L.T.; Li J.; Luan Y.; Siqueira-Neto J.L.; Li R.; Drugs for the treatment of zika virus infection. J Med Chem 2020,63(2),470-489","journal-title":"J Med Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.antiviral.2018.12.016","volume":"163","author":"Lim S.P.","year":"2019","unstructured":"Lim S.P.; Dengue drug discovery: Progress, challenges and outlook. Antiviral Res 2019,163,156-178","journal-title":"Antiviral Res"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1002\/cmdc.202000464","volume":"15","author":"Felicetti T.","year":"2020","unstructured":"Felicetti T.; Manfroni G.; Cecchetti V.; Cannalire R.; Broad-spectrum flavivirus inhibitors: A medicinal chemistry point of view. ChemMedChem 2020,15(24),2391-2419","journal-title":"ChemMedChem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"126","DOI":"10.4161\/hv.26549","volume":"10","author":"Verma R.","year":"2014","unstructured":"Verma R.; Khanna P.; Chawla S.; Yellow fever vaccine: An effective vaccine for travelers. Hum Vaccin Immunother 2014,10(1),126-128","journal-title":"Hum Vaccin Immunother"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3201\/eid1901.120458","volume":"19","author":"Heinz F.X.","year":"2013","unstructured":"Heinz F.X.; Stiasny K.; Holzmann H.; Grgic-Vitek M.; Kriz B.; Essl A.; Kundi M.; Vaccination and tick-borne encephalitis, central Europe. Emerg Infect Dis 2013,19(1),69-76","journal-title":"Emerg Infect Dis"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.vaccine.2016.02.004","volume":"34","author":"Halstead S.B.","year":"2016","unstructured":"Halstead S.B.; Russell P.K.; Protective and immunological behavior of chimeric yellow fever dengue vaccine. Vaccine 2016,34(14),1643-1647","journal-title":"Vaccine"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/QCO.0000000000000394","volume":"30","author":"Robinson M.L.","year":"2017","unstructured":"Robinson M.L.; Durbin A.P.; Dengue vaccines: Implications for dengue control. Curr Opin Infect Dis 2017,30(5),449-454","journal-title":"Curr Opin Infect Dis"},{"key":"ref=29","year":"2018","unstructured":"The Weekly Epidemiological Record (WER),  WHO Available from: 2018"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/life11070615","volume":"11","author":"Zhao R.","year":"2021","unstructured":"Zhao R.; Wang M.; Cao J.; Shen J.; Zhou X.; Wang D.; Cao J.; Flavivirus: From structure to therapeutics development. Life (Basel) 2021,11(7),1-25","journal-title":"Life (Basel)"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"e3000130","DOI":"10.1371\/journal.pbio.3000130","volume":"17","author":"Vogels C.B.F.","year":"2019","unstructured":"Vogels C.B.F.; R\u00fcckert C.; Cavany S.M.; Perkins T.A.; Ebel G.D.; Grubaugh N.D.; Arbovirus coinfection and co-transmission: A neglected public health concern? PLoS Biol 2019,17(1),e3000130","journal-title":"PLoS Biol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12879-018-2976-1","volume":"18","author":"Carrillo-Hern\u00e1ndez M.Y.","year":"2018","unstructured":"Carrillo-Hern\u00e1ndez M.Y.; Ruiz-Saenz J.; Villamizar L.J.; G\u00f3mez-Rangel S.Y.; Mart\u00ednez-Gutierrez M.; Co-circulation and simultaneous co-infection of dengue, chikungunya, and zika viruses in patients with febrile syndrome at the Colombian-Venezuelan border. BMC Infect Dis 2018,18(1),61","journal-title":"BMC Infect Dis"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.4269\/ajtmh.18-0426","volume":"99","author":"Laredo-Tiscare\u00f1o S.V.","year":"2018","unstructured":"Laredo-Tiscare\u00f1o S.V.; Garza-Hernandez J.A.; Salazar M.I.; De Luna-Santillana E.J.; Tangudu C.S.; Cetina-Trejo R.C.; Doria-Cobos G.L.; Carmona-Aguirre S.D.; Garcia-Rejon J.E.; Machain-Williams C.; Blitvich B.J.; P\u00e9rez M.A.R.; Surveillance for Flaviviruses Near the Mexico-U.S. Border: Co-circulation of Dengue Virus Serotypes 1, 2, and 3 and West Nile Virus in Tamaulipas, Northern Mexico, 2014-2016. Am J Trop Med Hyg 2018,99(5),1308-1317","journal-title":"Am J Trop Med Hyg"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"4448","DOI":"10.1021\/acs.chemrev.7b00719","volume":"118","author":"Barrows N.J.","year":"2018","unstructured":"Barrows N.J.; Campos R.K.; Liao K-C.; Prasanth K.R.; Soto-Acosta R.; Yeh S-C.; Schott-Lerner G.; Pompon J.; Sessions O.M.; Bradrick S.S.; Garcia-Blanco M.A.; Biochemistry and molecular biology of flaviviruses. Chem Rev 2018,118(8),4448-4482","journal-title":"Chem Rev"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.tips.2013.11.006","volume":"35","author":"Lou Z.","year":"2014","unstructured":"Lou Z.; Sun Y.; Rao Z.; Current progress in antiviral strategies. Trends Pharmacol Sci 2014,35(2),86-102","journal-title":"Trends Pharmacol Sci"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1002\/med.21664","volume":"40","author":"Ji X.","year":"2020","unstructured":"Ji X.; Li Z.; Medicinal chemistry strategies toward host targeting antiviral agents. Med Res Rev 2020,40(5),1519-1557","journal-title":"Med Res Rev"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1016\/j.drudis.2021.05.008","volume":"26","author":"Shyr Z.A.","year":"2021","unstructured":"Shyr Z.A.; Cheng Y.S.; Lo D.C.; Zheng W.; Drug combination therapy for emerging viral diseases. Drug Discov Today 2021,26(10),2367-2376","journal-title":"Drug Discov Today"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.antiviral.2010.04.014","volume":"87","author":"Pastorino B.","year":"2010","unstructured":"Pastorino B.; Nougair\u00e8de A.; Wurtz N.; Gould E.; de Lamballerie X.; Role of host cell factors in flavivirus infection: Implications for pathogenesis and development of antiviral drugs. Antiviral Res 2010,87(3),281-294","journal-title":"Antiviral Res"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1146\/annurev-med-052915-015720","volume":"68","author":"Naggie S.","year":"2017","unstructured":"Naggie S.; Muir A.J.; Oral combination therapies for hepatitis C virus infection: Successes, challenges, and unmet needs. Annu Rev Med 2017,68,345-358","journal-title":"Annu Rev Med"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0140-6736(18)31311-4","volume":"392","author":"Ghosn J.","year":"2018","unstructured":"Ghosn J.; Taiwo B.; Seedat S.; Autran B.; Katlama C.; HIV. Lancet 2018,392(10148),685-697","journal-title":"Lancet"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/v9110338","volume":"9","author":"Zhang X.","year":"2017","unstructured":"Zhang X.; Jia R.; Shen H.; Wang M.; Yin Z.; Cheng A.; Structures and functions of the envelope glycoprotein in flavivirus infections. Viruses 2017,9(11),1-14","journal-title":"Viruses"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1517\/17460441.2016.1160887","volume":"11","author":"Kok W.M.","year":"2016","unstructured":"Kok W.M.; New developments in flavivirus drug discovery. Expert Opin Drug Discov 2016,11(5),433-445","journal-title":"Expert Opin Drug Discov"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"6986","DOI":"10.1073\/pnas.0832193100","volume":"100","author":"Modis Y.","year":"2003","unstructured":"Modis Y.; Ogata S.; Clements D.; Harrison S.C.; A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci USA 2003,100(12),6986-6991","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.antiviral.2009.09.007","volume":"84","author":"Kampmann T.","year":"2009","unstructured":"Kampmann T.; Yennamalli R.; Campbell P.; Stoermer M.J.; Fairlie D.P.; Kobe B.; Young P.R.; In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses. Antiviral Res 2009,84(3),234-241","journal-title":"Antiviral Res"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1261\/rna.2120410","volume":"16","author":"Villordo S.M.","year":"2010","unstructured":"Villordo S.M.; Alvarez D.E.; Gamarnik A.V.; A balance between circular and linear forms of the dengue virus genome is crucial for viral replication. RNA 2010,16(12),2325-2335","journal-title":"RNA"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1146\/annurev-virology-110615-042334","volume":"3","author":"Byk L.A.","year":"2016","unstructured":"Byk L.A.; Gamarnik A.V.; Properties and functions of the dengue virus capsid protein. Annu Rev Virol 2016,3(1),263-281","journal-title":"Annu Rev Virol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1128\/AAC.01429-12","volume":"57","author":"Byrd C.M.","year":"2013","unstructured":"Byrd C.M.; Dai D.; Grosenbach D.W.; Berhanu A.; Jones K.F.; Cardwell K.B.; Schneider C.; Wineinger K.A.; Page J.M.; Harver C.; Stavale E.; Tyavanagimatt S.; Stone M.A.; Bartenschlager R.; Scaturro P.; Hruby D.E.; Jordan R.; A novel inhibitor of dengue virus replication that targets the capsid protein. Antimicrob Agents Chemother 2013,57(1),15-25","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.antiviral.2015.03.014","volume":"118","author":"Luo D.","year":"2015","unstructured":"Luo D.; Vasudevan S.G.; Lescar J.; The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development. Antiviral Res 2015,118,148-158","journal-title":"Antiviral Res"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"9354","DOI":"10.1021\/acs.jmedchem.5b01441","volume":"58","author":"Behnam M.A.M.","year":"2015","unstructured":"Behnam M.A.M.; Graf D.; Bartenschlager R.; Zlotos D.P.; Klein C.D.; Discovery of nanomolar dengue and west nile virus protease inhibitors containing a 4-benzyloxyphenylglycine residue. J Med Chem 2015,58(23),9354-9370","journal-title":"J Med Chem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/cr.2017.88","volume":"27","author":"Li Z.","year":"2017","unstructured":"Li Z.; Brecher M.; Deng Y.Q.; Zhang J.; Sakamuru S.; Liu B.; Huang R.; Koetzner C.A.; Allen C.A.; Jones S.A.; Chen H.; Zhang N.N.; Tian M.; Gao F.; Lin Q.; Banavali N.; Zhou J.; Boles N.; Xia M.; Kramer L.D.; Qin C-F.; Li H.; Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction. Cell Res 2017,27(8),1046-1064","journal-title":"Cell Res"},{"key":"ref=51","first-page":"[Epub ahead of print]","author":"Du Pont K.E.","year":"2021","unstructured":"Du Pont K.E.; McCullagh M.; Geiss B.J.; Conserved motifs in the flavivirus NS3 RNA helicase enzyme. Wiley Interdiscip Rev RNA 2021,[Epub ahead of print]","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1128\/AAC.02251-12","volume":"57","author":"Byrd C.M.","year":"2013","unstructured":"Byrd C.M.; Grosenbach D.W.; Berhanu A.; Dai D.; Jones K.F.; Cardwell K.B.; Schneider C.; Yang G.; Tyavanagimatt S.; Harver C.; Wineinger K.A.; Page J.; Stavale E.; Stone M.A.; Fuller K.P.; Lovejoy C.; Leeds J.M.; Hruby D.E.; Jordan R.; Novel benzoxazole inhibitor of dengue virus replication that targets the NS3 helicase. Antimicrob Agents Chemother 2013,57(4),1902-1912","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/rmv.1835","volume":"25","author":"Zmurko J.","year":"2015","unstructured":"Zmurko J.; Neyts J.; Dallmeier K.; Flaviviral NS4b, chameleon and jack-in-the-box roles in viral replication and pathogenesis, and a molecular target for antiviral intervention. Rev Med Virol 2015,25(4),205-223","journal-title":"Rev Med Virol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"e0234920","DOI":"10.1128\/AAC.02349-20","volume":"65","author":"Fikatas A.","year":"2021","unstructured":"Fikatas A.; Vervaeke P.; Meyen E.; Llor N.; Ordeix S.; Boonen I.; Bletsa M.; Kafetzopoulou L.E.; Lemey P.; Amat M.; Pannecouque C.; Schols D.; A novel series of indole alkaloid derivatives inhibit dengue and zika virus infection by interference with the viral replication complex. Antimicrob Agents Chemother 2021,65(8),e0234920","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/nar\/gkg277","volume":"31","author":"Bruenn J.A.","year":"2003","unstructured":"Bruenn J.A.; A structural and primary sequence comparison of the viral RNA-dependent RNA polymerases. Nucleic Acids Res 2003,31(7),1821-1829","journal-title":"Nucleic Acids Res"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.antiviral.2016.09.007","volume":"134","author":"Tarantino D.","year":"2016","unstructured":"Tarantino D.; Cannalire R.; Mastrangelo E.; Croci R.; Querat G.; Barreca M.L.; Bolognesi M.; Manfroni G.; Cecchetti V.; Milani M.; Targeting flavivirus RNA dependent RNA polymerase through a pyridobenzothiazole inhibitor. Antiviral Res 2016,134,226-235","journal-title":"Antiviral Res"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3389\/fmicb.2017.00651","volume":"8","author":"Simanjuntak Y.","year":"2017","unstructured":"Simanjuntak Y.; Liang J.J.; Lee Y.L.; Lin Y.L.; Japanese encephalitis virus exploits dopamine D2 receptor-phospholipase C to target dopaminergic human neuronal cells. Front Microbiol 2017,8,651","journal-title":"Front Microbiol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1021\/acs.jmedchem.9b01779","volume":"63","author":"Chen W.C.","year":"2020","unstructured":"Chen W.C.; Simanjuntak Y.; Chu L.W.; Ping Y.H.; Lee Y.L.; Lin Y.L.; Li W.S.; Benzenesulfonamide derivatives as calcium\/calmodulin-dependent protein kinase inhibitors and antiviral agents against dengue and zika virus infections. J Med Chem 2020,63(3),1313-1327","journal-title":"J Med Chem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/eji.201040447","volume":"40","author":"Mulhern O.","year":"2010","unstructured":"Mulhern O.; Bowie A.G.; Unexpected roles for DEAD-box protein 3 in viral RNA sensing pathways. Eur J Immunol 2010,40(4),933-935","journal-title":"Eur J Immunol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1021\/acs.jmedchem.8b01403","volume":"62","author":"Brai A.","year":"2019","unstructured":"Brai A.; Martelli F.; Riva V.; Garbelli A.; Fazi R.; Zamperini C.; Pollutri A.; Falsitta L.; Ronzini S.; Maccari L.; Maga G.; Giannecchini S.; Botta M.; DDX3X helicase inhibitors as a new strategy to fight the west nile virus infection. J Med Chem 2019,62(5),2333-2347","journal-title":"J Med Chem"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"4585","DOI":"10.1021\/jm100054f","volume":"53","author":"Evans C.G.","year":"2010","unstructured":"Evans C.G.; Chang L.; Gestwicki J.E.; Heat shock protein 70 (hsp70) as an emerging drug target. J Med Chem 2010,53(12),4585-4602","journal-title":"J Med Chem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1074\/mcp.R116.065649","volume":"16","author":"Gerold G.","year":"2017","unstructured":"Gerold G.; Bruening J.; Weigel B.; Pietschmann T.; Protein interactions during the flavivirus and hepacivirus life cycle. Mol Cell Proteomics 2017,16(4)(Suppl. 1),S75-S91","journal-title":"Mol Cell Proteomics"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1080\/22221751.2018.1557988","volume":"8","author":"Pujhari S.","year":"2019","unstructured":"Pujhari S.; Brustolin M.; Macias V.M.; Nissly R.H.; Nomura M.; Kuchipudi S.V.; Rasgon J.L.; Heat shock protein 70 (Hsp70) mediates Zika virus entry, replication, and egress from host cells. Emerg Microbes Infect 2019,8(1),8-16","journal-title":"Emerg Microbes Infect"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.cell.2015.10.046","volume":"163","author":"Taguwa S.","year":"2015","unstructured":"Taguwa S.; Maringer K.; Li X.; Bernal-Rubio D.; Rauch J.N.; Gestwicki J.E.; Andino R.; Fernandez-Sesma A.; Frydman J.; Defining Hsp70 subnetworks in dengue virus replication reveals key vulnerability in flavivirus infection. Cell 2015,163(5),1108-1123","journal-title":"Cell"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1016\/j.celrep.2017.11.054","volume":"21","author":"Puschnik A.S.","year":"2017","unstructured":"Puschnik A.S.; Marceau C.D.; Ooi Y.S.; Majzoub K.; Rinis N.; Contessa J.N.; Carette J.E.; A small-molecule oligosaccharyltransferase inhibitor with pan-flaviviral activity. Cell Rep 2017,21(11),3032-3039","journal-title":"Cell Rep"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"5777","DOI":"10.1073\/pnas.1101143108","volume":"108","author":"Hoffmann H.H.","year":"2011","unstructured":"Hoffmann H.H.; Kunz A.; Simon V.A.; Palese P.; Shaw M.L.; Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis. Proc Natl Acad Sci USA 2011,108(14),5777-5782","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.antiviral.2017.10.001","volume":"147","author":"Liu B.","year":"2017","unstructured":"Liu B.; Tang L.; Zhang X.; Ma J.; Sehgal M.; Cheng J.; Zhang X.; Zhou Y.; Du Y.; Kulp J.; Guo J.T.; Chang J.; A cell-based high throughput screening assay for the discovery of cGAS-STING pathway agonists. Antiviral Res 2017,147,37-46","journal-title":"Antiviral Res"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1128\/JVI.02202-15","volume":"90","author":"Pattabhi S.","year":"2015","unstructured":"Pattabhi S.; Wilkins C.R.; Dong R.; Knoll M.L.; Posakony J.; Kaiser S.; Mire C.E.; Wang M.L.; Ireton R.C.; Geisbert T.W.; Bedard K.M.; Iadonato S.P.; Loo Y-M.; Gale M.; Targeting innate immunity for antiviral therapy through small molecule agonists of the RLR pathway. J Virol 2015,90(5),2372-2387","journal-title":"J Virol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mBio.00452-17","volume":"8","author":"Pryke K.M.","year":"2017","unstructured":"Pryke K.M.; Abraham J.; Sali T.M.; Gall B.J.; Archer I.; Liu A.; Bambina S.; Baird J.; Gough M.; Chakhtoura M.; Haddad E.K.; Kirby I.T.; Nilsen A.; Streblow D.N.; Hirsch A.J.; Smith J.L.; DeFilippis V.R.; A novel agonist of the TRIF pathway induces a cellular state refractory to replication of zika, chikungunya, and dengue viruses. MBio 2017,8(3),1-22","journal-title":"MBio"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"e1005324","DOI":"10.1371\/journal.ppat.1005324","volume":"11","author":"Sali T.M.","year":"2015","unstructured":"Sali T.M.; Pryke K.M.; Abraham J.; Liu A.; Archer I.; Broeckel R.; Staverosky J.A.; Smith J.L.; Al-Shammari A.; Amsler L.; Sheridan K.; Nilsen A.; Streblow D.N.; DeFilippis V.R.; Characterization of a novel human-specific STING agonist that elicits antiviral activity against emerging alphaviruses. PLoS Pathog 2015,11(12),e1005324","journal-title":"PLoS Pathog"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.chembiol.2018.05.011","volume":"25","author":"de Wispelaere M.","year":"2018","unstructured":"de Wispelaere M.; Lian W.; Potisopon S.; Li P.C.; Jang J.; Ficarro S.B.; Clark M.J.; Zhu X.; Kaplan J.B.; Pitts J.D.; Wales T.E.; Wang J.; Engen J.R.; Marto J.A.; Gray N.S.; Yang P.L.; Inhibition of flaviviruses by targeting a conserved pocket on the viral envelope protein. Cell Chem Biol 2018,25(8),1006-1016.e8","journal-title":"Cell Chem Biol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/978-1-62703-484-5_18","volume":"1030","author":"Nitsche C.","year":"2013","unstructured":"Nitsche C.; Klein C.D.; Fluorimetric and HPLC-based dengue virus protease assays using a FRET substrate. Methods Mol Biol 2013,1030,221-236","journal-title":"Methods Mol Biol"},{"key":"ref=73","year":"1976","unstructured":"New derivative of 2-benzamido-5-nitrothiazoles. 1976"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1093\/jac\/dkp117","volume":"63","author":"Chan-Bacab M.J.","year":"2009","unstructured":"Chan-Bacab M.J.; Hern\u00e1ndez-N\u00fa\u00f1ez E.; Navarrete-V\u00e1zquez G.; Nitazoxanide, tizoxanide and a new analogue [4-nitro-N-(5-nitro-1,3-thiazol-2-yl)benzamide; NTB] inhibit the growth of kinetoplastid parasites (Trypanosoma cruzi and Leishmania mexicana) in vitro. J Antimicrob Chemother 2009,63(6),1292-1293","journal-title":"J Antimicrob Chemother"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/cmdc.201000475","volume":"6","author":"Ballard T.E.","year":"2011","unstructured":"Ballard T.E.; Wang X.; Olekhnovich I.; Koerner T.; Seymour C.; Salamoun J.; Warthan M.; Hoffman P.S.; Macdonald T.L.; Synthesis and antimicrobial evaluation of nitazoxanide-based analogues: Identification of selective and broad spectrum activity. ChemMedChem 2011,6(2),362-377","journal-title":"ChemMedChem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.1021\/jm200153p","volume":"54","author":"Stachulski A.V.","year":"2011","unstructured":"Stachulski A.V.; Pidathala C.; Row E.C.; Sharma R.; Berry N.G.; Iqbal M.; Bentley J.; Allman S.A.; Edwards G.; Helm A.; Hellier J.; Korba B.E.; Semple J.E.; Rossignol J-F.; Thiazolides as novel antiviral agents. 1. Inhibition of hepatitis B virus replication. J Med Chem 2011,54(12),4119-4132","journal-title":"J Med Chem"},{"key":"ref=77","author":"Wang Y.","year":"2013","unstructured":"Wang Y.; Wang J.; Dong Z.; Yu G.; Cheng X.; Jiao X.; Process for preparation of parasiticide nitazoxanide. 2013"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.antiviral.2019.03.004","volume":"167","author":"Cannalire R.","year":"2019","unstructured":"Cannalire R.; Tarantino D.; Piorkowski G.; Carletti T.; Massari S.; Felicetti T.; Barreca M.L.; Sabatini S.; Tabarrini O.; Marcello A.; Milani M.; Cecchetti V.; Mastrangelo E.; Manfroni G.; Querat G.; Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions. Antiviral Res 2019,167,6-12","journal-title":"Antiviral Res"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1021\/acsmedchemlett.9b00619","volume":"11","author":"Cannalire R.","year":"2020","unstructured":"Cannalire R.; Ki Chan K.W.; Burali M.S.; Gwee C.P.; Wang S.; Astolfi A.; Massari S.; Sabatini S.; Tabarrini O.; Mastrangelo E.; Barreca M.L.; Cecchetti V.; Vasudevan S.G.; Manfroni G.; Pyridobenzothiazolones exert potent anti-dengue activity by hampering multiple functions of NS5 polymerase. ACS Med Chem Lett 2020,11(5),773-782","journal-title":"ACS Med Chem Lett"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"112992","DOI":"10.1016\/j.ejmech.2020.112992","volume":"210","author":"Felicetti T.","year":"2021","unstructured":"Felicetti T.; Burali M.S.; Gwee C.P.; Ki Chan K.W.; Alonso S.; Massari S.; Sabatini S.; Tabarrini O.; Barreca M.L.; Cecchetti V.; Vasudevan S.G.; Manfroni G.; Sustainable, three-component, one-pot procedure to obtain active anti-flavivirus agents. Eur J Med Chem 2021,210,112992","journal-title":"Eur J Med Chem"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"e0008156","DOI":"10.1371\/journal.pntd.0008156","volume":"14","author":"Caracciolo I.","year":"2020","unstructured":"Caracciolo I.; Mora-Cardenas E.; Aloise C.; Carletti T.; Segat L.; Burali M.S.; Chiarvesio A.; Totis V.; Av\u0161i\u010d-\u017dupanc T.; Mastrangelo E.; Manfroni G.; D\u2019Agaro P.; Marcello A.; Comprehensive response to Usutu virus following first isolation in blood donors in the Friuli Venezia Giulia region of Italy: Development of recombinant NS1-based serology and sensitivity to antiviral drugs. PLoS Negl Trop Dis 2020,14(3),e0008156","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=82","first-page":"[Epub ahead of print]","author":"Laxmikeshav K.","year":"2021","unstructured":"Laxmikeshav K.; Kumari P.; Shankaraiah N.; Expedition of sulfur containing heterocyclic derivatives as cytotoxic agents in medicinal chemistry: A decade update. Med Res Rev 2021,[Epub ahead of print]","journal-title":"Med Res Rev"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1074\/jbc.M114.607341","volume":"290","author":"Tay M.Y.F.","year":"2015","unstructured":"Tay M.Y.F.; Saw W.G.; Zhao Y.; Chan K.W.K.; Singh D.; Chong Y.; Forwood J.K.; Ooi E.E.; Gr\u00fcber G.; Lescar J.; Luo D.; Vasudevan S.G.; The C-terminal 50 amino acid residues of dengue NS3 protein are important for NS3-NS5 interaction and viral replication. J Biol Chem 2015,290(4),2379-2394","journal-title":"J Biol Chem"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"14362","DOI":"10.1074\/jbc.M110.214189","volume":"286","author":"Zou G.","year":"2011","unstructured":"Zou G.; Chen Y.L.; Dong H.; Lim C.C.; Yap L.J.; Yau Y.H.; Shochat S.G.; Lescar J.; Shi P.Y.; Functional analysis of two cavities in flavivirus NS5 polymerase. J Biol Chem 2011,286(16),14362-14372","journal-title":"J Biol Chem"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"10678","DOI":"10.1074\/jbc.M607273200","volume":"282","author":"Malet H.","year":"2007","unstructured":"Malet H.; Egloff M.P.; Selisko B.; Butcher R.E.; Wright P.J.; Roberts M.; Gruez A.; Sulzenbacher G.; Vonrhein C.; Bricogne G.; Mackenzie J.M.; Khromykh A.A.; Davidson A.D.; Canard B.; Crystal structure of the RNA polymerase domain of the west nile virus non-structural protein 5. J Biol Chem 2007,282(14),10678-10689","journal-title":"J Biol Chem"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.3390\/v3091739","volume":"3","author":"Gebhard L.G.","year":"2011","unstructured":"Gebhard L.G.; Filomatori C.V.; Gamarnik A.V.; Functional RNA elements in the dengue virus genome. Viruses 2011,3(9),1739-1756","journal-title":"Viruses"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1021\/ml400204n","volume":"4","author":"Li X.","year":"2013","unstructured":"Li X.; Srinivasan S.R.; Connarn J.; Ahmad A.; Young Z.T.; Kabza A.M.; Zuiderweg E.R.P.; Sun D.; Gestwicki J.E.; Analogues of the allosteric Heat Shock Protein 70 (Hsp70) inhibitor, MKT-077, as anti-cancer agents. ACS Med Chem Lett 2013,4,1042-1047","journal-title":"ACS Med Chem Lett"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"17992","DOI":"10.1073\/pnas.2003056117","volume":"117","author":"Xia H.","year":"2020","unstructured":"Xia H.; Xie X.; Zou J.; Noble C.G.; Russell W.K.; Holthauzen L.M.F.; Choi K.H.; White M.A.; Shi P.Y.; A cocrystal structure of dengue capsid protein in complex of inhibitor. Proc Natl Acad Sci USA 2020,117(30),17992-18001","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=89","author":"Dai D.","year":"2014","unstructured":"Dai D.; Burgeson J.R.; Thienopyridine derivatives for the treatment and prevention of dengue virus infections. 2014"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ejmech.2016.05.043","volume":"121","author":"Saudi M.","year":"2016","unstructured":"Saudi M.; Zmurko J.; Kaptein S.; Rozenski J.; Gadakh B.; Chaltin P.; Marchand A.; Neyts J.; Van Aerschot A.; Synthetic strategy and antiviral evaluation of diamide containing heterocycles targeting dengue and yellow fever virus. Eur J Med Chem 2016,121,158-168","journal-title":"Eur J Med Chem"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1021\/acsinfecdis.9b00010","volume":"5","author":"Zhang X.","year":"2019","unstructured":"Zhang X.; Liu B.; Tang L.; Su Q.; Hwang N.; Sehgal M.; Cheng J.; Ma J.; Zhang X.; Tan Y.; Zhou Y.; Duan Z.; DeFilippis V.R.; Viswanathan U.; Kulp J.; Du Y.; Guo J.T.; Chang J.; Discovery and mechanistic study of a novel human-stimulator-of-interferon-genes agonist. ACS Infect Dis 2019,5(7),1139-1149","journal-title":"ACS Infect Dis"},{"key":"ref=92","author":"Banerjee M.","year":"2018","unstructured":"Banerjee M.; Middya S.; Basu S.; Ghosh R.; Pryde D.; Yadav D.; Shrivastava R.; Surya A.; Preparation of fused (hetero)arylthiazine carboxamides as STING modulators. 2018"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"5533","DOI":"10.1128\/JVI.00365-14","volume":"88","author":"Smith J.L.","year":"2014","unstructured":"Smith J.L.; Stein D.A.; Shum D.; Fischer M.A.; Radu C.; Bhinder B.; Djaballah H.; Nelson J.A.; Fr\u00fch K.; Hirsch A.J.; Inhibition of dengue virus replication by a class of small-molecule compounds that antagonize dopamine receptor d4 and downstream mitogen-activated protein kinase signaling. J Virol 2014,88(10),5533-5542","journal-title":"J Virol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1021\/jm960072u","volume":"39","author":"Rowley M.","year":"1996","unstructured":"Rowley M.; Broughton H.B.; Collins I.; Baker R.; Emms F.; Marwood R.; Patel S.; Patel S.; Ragan C.I.; Freedman S.B.; Leeson P.D.; 5-(4-Chlorophenyl)-4-methyl-3-(1-(2-phenylethyl)piperidin-4-yl)isoxazole: A potent, selective antagonist at human cloned dopamine D4 receptors. J Med Chem 1996,39(10),1943-1945","journal-title":"J Med Chem"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.ejmech.2018.11.017","volume":"162","author":"Zhao C.","year":"2019","unstructured":"Zhao C.; Rakesh K.P.; Ravidar L.; Fang W.Y.; Qin H.L.; Pharmaceutical and medicinal significance of sulfur (S)-Containing motifs for drug discovery: A critical review. Eur J Med Chem 2019,162,679-734","journal-title":"Eur J Med Chem"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.antiviral.2019.02.008","volume":"164","author":"Pitts J.","year":"2019","unstructured":"Pitts J.; Hsia C.Y.; Lian W.; Wang J.; Pfeil M.P.; Kwiatkowski N.; Li Z.; Jang J.; Gray N.S.; Yang P.L.; Identification of small molecule inhibitors targeting the Zika virus envelope protein. Antiviral Res 2019,164,147-153","journal-title":"Antiviral Res"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1021\/jo502604p","volume":"80","author":"Feng Y.","year":"2015","unstructured":"Feng Y.; Yu Z-X.; Formal synthesis of (\u00b1)-galanthamine and (\u00b1)-lycoramine using Rh(I)-catalyzed [(3 + 2) + 1] cycloaddition of 1-ene-vinylcyclopropane and CO. J Org Chem 2015,80(3),1952-1956","journal-title":"J Org Chem"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1021\/acsmedchemlett.9b00681","volume":"11","author":"Brai A.","year":"2020","unstructured":"Brai A.; Boccuto A.; Monti M.; Marchi S.; Vicenti I.; Saladini F.; Trivisani C.I.; Pollutri A.; Trombetta C.M.; Montomoli E.; Riva V.; Garbelli A.; Nola E.M.; Zazzi M.; Maga G.; Dreassi E.; Botta M.; Exploring the implication of DDX3X in DENV infection: Discovery of the first-in-class DDX3X fluorescent inhibitor. ACS Med Chem Lett 2020,11(5),956-962","journal-title":"ACS Med Chem Lett"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1021\/acsmedchemlett.8b00583","volume":"10","author":"Vincetti P.","year":"2019","unstructured":"Vincetti P.; Kaptein S.J.F.; Costantino G.; Neyts J.; Radi M.; Scaffold morphing approach to expand the toolbox of broad-spectrum antivirals blocking dengue\/zika replication. ACS Med Chem Lett 2019,10(4),558-563","journal-title":"ACS Med Chem Lett"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1039\/b904521j","author":"Amat M.","year":"2009","unstructured":"Amat M.; Checa B.; Llor N.; Molins E.; Bosch J.; Enantioselective total synthesis of the indole alkaloid 16-episilicine. Chem Commun (Camb) 2009(20),2935-2937","journal-title":"Chem Commun (Camb)"},{"key":"ref=101","author":"Contessa J.N.","year":"2016","unstructured":"Contessa J.N.; Golden J.E.; Flaherty D.P.; Preparation of benzenesulfonylamide derivatives as inhibitors of N-linked glycosylation. 2016"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/s41586-021-03990-6","volume":"598","author":"Kaptein S.J.F.","year":"2021","unstructured":"Kaptein S.J.F.; Goethals O.; Kiemel D.; Marchand A.; Kesteleyn B.; Bonfanti J.; Bardiot D.; Stoops B.; Jonckers T.H.M.; Dallmeier K.; Geluykens P.; Thys K.; Crabbe M.; Chatel-Chaix L.; M\u00fcnster M.; Querat G.; Touret F.; de Lamballerie X.; Raboisson P.; Simmen K.; Chaltin P.; Bartenschlager R.; Van Loock M.; Neyts J.; A pan-serotype dengue virus inhibitor targeting the NS3\u2013NS4B interaction. Nature 2021,598,504-509","journal-title":"Nature"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.abb2181","volume":"13","author":"Moquin S.A.","year":"2021","unstructured":"Moquin S.A.; Simon O.; Karuna R.; Lakshminarayana S.B.; Yokokawa F.; Wang F.; Saravanan C.; Zhang J.; Day C.W.; Chan K.; Wang Q.Y.; Lu S.; Dong H.; Wan K.F.; Lim S.P.; Liu W.; Seh C.C.; Chen Y.L.; Xu H.; Barkan D.T.; Kounde C.S.; Sim W.L.S.; Wang G.; Yeo H.Q.; Zou B.; Chan W.L.; Ding M.; Song J.G.; Li M.; Osborne C.; Blasco F.; Sarko C.; Beer D.; Bonamy G.M.C.; Sasseville V.G.; Shi P.Y.; Diagana T.T.; Yeung B.K.S.; Gu F.; NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models. Sci Transl Med 2021,13(579),1-14","journal-title":"Sci Transl Med"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867329666220610211441","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/205875\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867329666220610211441","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T09:43:45Z","timestamp":1698659025000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/205875\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":103,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867329666220610211441","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-11-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}